FDA Approved: EPTIFIBATIDE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved Baxter Healthcare's supplemental application for eptifibatide (brand Integrilin). This notice reflects a supplemental approval rather than a new dr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease

Drugs mentioned

• Integrilin (Eptifibatide)

Snippet

SUPPL AP for EPTIFIBATIDE (EPTIFIBATIDE)